The results will define an essential role of the PHEX/cDMP1 axis in regulating FGF23, and identify novel therapeutic targets to treat disorders of FGF23 - excess, including CKD.
|Effective start/end date||7/1/15 → 6/30/21|
- National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK101730-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.